Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep

Critical Care

Volumn 12, Issue 6, 2008, Pages

  Waerhaug, Kristine ^a   Kirov, Mikhail Y ^a,b   Kuzkov, Vsevolod V ^a,b   Kuklin, Vladimir N ^a   Bjertnaes, Lars J ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NORTHERN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; OLEIC ACID; OXYGEN; FIBRINOLYTIC AGENT; PROTEIN C; RECOMBINANT PROTEIN;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD SAMPLING; CONTINUOUS INFUSION; CONTROLLED STUDY; DATA ANALYSIS; HEART INDEX; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEMODYNAMIC PARAMETERS; HYPOXEMIA; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; LUNG GAS EXCHANGE; MEAN ARTERIAL PRESSURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SHEEP; THERMODILUTION; VASCULAR RESISTANCE; WAKEFULNESS; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; LUNG INJURY; NORWAY; RANDOMIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; LUNG INJURY; NORWAY; OLEIC ACID; PROTEIN C; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SHEEP;

EID: 57449098600     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7128     Document Type: Article

References (49)

1. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 2000, 342:1301-1308. 10.1056/NEJM200005043421801 10793162
2. Quinlan GJ Lamb NJ Evans TW Gutteridge JM Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome Crit Care Med 1996, 24:241-246. 10.1097/ 00003246-199602000-00010 8605795
3. Baughman RP Stein E MacGee J Rashkin M Sahebjami H Changes in fatty acids in phospholipids of the bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome Clin Chem 1984, 30:521-523. 6705194
4. Bursten SL Federighi DA Parsons P Harris WE Abraham E Moore EE Jr Moore FA Bianco JA Singer JW Repine JE An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome Crit Care Med 1996, 24:1129-1136. 10.1097/ 00003246-199607000-00011 8674324
5. Schuster DP ARDS: Clinical lessons from the oleic acid model of acute lung injury Am J Respir Crit Care Med 1994, 149:245-260. 8111590
6. Fulcher CA Gardiner JE Griffin JH Zimmerman TS Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V Blood 1984, 63:486-489. 6419799
7. Walker FJ Sexton PW Esmon CT The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V Biochim Biophys Acta 1979, 571:333-342. 508770
8. Bilbault P Lavaux T Launoy A Gaub MP Meyer N Oudet P Pottecher T Jaeger A Schneider F Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: A cohort study in septic shock patients Crit Care Med 2007, 35:69-75. 10.1097/01.CCM.0000251133.26979.F4 17133181
9. Feistritzer C Riewald M Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation Blood 2005, 105:3178-3184. 10.1182/blood-2004-10-3985 15626732
10. Shires GT Fisher O Murphy P Williams S Barber A Johnson G Davis B Pahulu S Recombinant activated protein C induces dose-dependent changes in inflammatory mediators, tissue damage, and apoptosis in in vivo rat model of sepsis Surg Infect (Larchmt) 2007, 8:377-386. 10.1089/ sur.2006.082 17635061
11. White B Schmidt M Murphy C Livingstone W O'Toole D Lawler M O'Neill L Kelleher D Schwarz HP Smith OP Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line Br J Haematol 2000, 110:130-134. 10.1046/j.1365-2141.2000.02128.x 10930989
12. Bernard GR Vincent JL Laterre PF LaRosa SP Dhainaut JF Lopez-Rodriguez A Steingrub JS Garber GE Helterbrand JD Ely EW Fisher CJ Jr Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001 11236773
13. Dhainaut JF Laterre PF Janes JM Bernard GR Artigas A Bakker J Riess H Basson BR Charpentier J Utterback BG Vincent JL Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: Data from the PROWESS trial Intensive Care Med 2003, 29:894-903. 12712239
14. Shorr AF Bernard GR Dhainaut JF Russell JR Macias WL Nelson DR Sundin DP Protein C concentrations in severe sepsis: An early directional change in plasma levels predicts outcome Crit Care 2006, 10:R92. 1550956 16780598 10.1186/cc4946
15. Matthay MA Ware LB Plasma protein C levels in patients with acute lung injury: Prognostic significance Crit Care Med 2004, 32:S229-S232. 10.1097/01.CCM.0000126121.56990.D3 15118523
16. Maybauer MO Maybauer DM Fraser JF Traber LD Westphal M Enkhbaatar P Cox RA Huda R Hawkins HK Morita N Murakami K Mizutani A Herndon DN Traber DL Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis Crit Care Med 2006, 34:2432-2438. 10.1097/01.CCM.0000230384.61350.FA 16810106
17. Wang Z Su F Rogiers P Vincent JL Beneficial effects of recombinant human activated protein C in a ewe model of septic shock Crit Care Med 2007, 35:2594-2600. 17901839
18. Waerhaug K Kuklin VN Kirov MY Sovershaev MA Langbakk B Ingebretsen OC Ytrehus K Bjertnaes LJ Recombinant human activated protein C attenuates endotoxin-induced lung injury in awake sheep Crit Care 2008, 12:R104. 2575593 18702832 10.1186/cc6985
19. Nielsen JS Larsson A Rix T Nyboe R Gjedsted J Krog J Ledet T Tonnesen E The effect of activated protein C on plasma cytokine levels in a porcine model of acute endotoxemia Intensive Care Med 2007, 33:1085-1093. 10.1007/s00134-007-0631-1 17457574
20. Richard JC Bregeon F Leray V Le Bars D Costes N Tourvieille C Lavenne F Devouassoux-Shisheboran M Gimenez G Guerin C Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury Intensive Care Med 2007, 33:2199-2206. 10.1007/ s00134-007-0782-0 17671779
21. Robriquet L Collet F Tournoys A Prangère T Nevière R Fourrier F Guery BP Intravenous administration of activated protein C in Pseudomonas-induced lung injury: Impact on lung fluid balance and the inflammatory response Respir Res 2006, 7:41. 1435891 16553944 10.1186/ 1465-9921-7-41
22. Liu KD Levitt J Zhuo H Kallet RH Brady S Steingrub J Tidswell M Siegel MD Soto G Peterson MW Chesnutt MS Phillips C Weinacker A Thompson BT Eisner MD Matthay MA Randomized clinical trial of activated protein C for the treatment of acute lung injury Am J Respir Crit Care Med 2008, 178:618-623. 10.1164/rccm.200803-419OC 18565951
23. Kuklin VN Kirov MY Evgenov OV Sovershaev MA Sjoberg J Kirova SS Bjertnaes LJ Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep Crit Care Med 2004, 32:766-773. 10.1097/01.CCM.0000114575.08269.F6 15090960
24. Bjertnaes LJ Koizumi T Newman JH Inhaled nitric oxide reduces lung fluid filtration after endotoxin in awake sheep Am J Respir Crit Care Med 1998, 158:1416-1423. 9817688
25. Neumann P Hedenstierna G Ventilation-perfusion distributions in different porcine lung injury models Acta Anaesthesiol Scand 2001, 45:78-86. 10.1034/j.1399-6576.2001.450113.x 11152038
26. Sakka SG Ruhl CC Pfeiffer UJ Beale R McLuckie A Reinhart K Meier-Hellmann A Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution Intensive Care Med 2000, 26:180-187. 10.1007/s001340050043 10784306
27. Kirov MY Kuzkov VV Kuklin VN Waerhaug K Bjertnaes LJ Extravascular lung water assessed by transpulmonary single thermodilution and postmortem gravimetry in sheep Crit Care 2004, 8:R451. 1065070 15566591 10.1186/ cc2974
28. Katzenelson R Perel A Berkenstadt H Preisman S Kogan S Sternik L Segal E Accuracy of transpulmonary thermodilution versus gravimetric measurement of extravascular lung water Crit Care Med 2004, 32:1550-1554. 10.1097/ 01.CCM.0000130995.18334.8B 15241101
29. Abraham E Carmody A Shenkar R Arcaroli J Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury Am J Physiol Lung Cell Mol Physiol 2000, 279:L1137-L1145. 11076804
30. Terada LS Dormish JJ Shanley PF Leff JA Anderson BO Repine JE Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion Am J Physiol 1992, 263:L394-L401. 1329531
31. Nill MR Oberyszyn TM Ross MS Oberyszyn AS Robertson FM Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/ HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice J Leukoc Biol 1995, 58:563-574. 7595058
32. Abraham E Neutrophils and acute lung injury Crit Care Med 2003, 31:S195-S199. 10.1097/01.CCM.0000057843.47705.E8 12682440
33. Brueckmann M Hoffmann U De Rossi L Weiler HM Liebe V Lang S Kaden JJ Borggrefe M Haase KK Huhle G Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes Cytokine 2004, 26:106-113. 10.1016/j.cyto.2004.01.004 15135804
34. Nick JA Coldren CD Geraci MW Poch KR Fouty BW O'Brien J Gruber M Zarini S Murphy RC Kuhn K Richter D Kast KR Abraham E Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis Blood 2004, 104:3878-3885. 10.1182/blood-2004-06-2140 15339848
35. Stephenson DA Toltl LJ Beaudin S Liaw PC Modulation of monocyte function by activated protein C, a natural anticoagulant J Immunol 2006, 177:2115-2122. 16887970
36. Sturn DH Kaneider NC Feistritzer C Djanani A Fukudome K Wiedermann CJ Expression and function of the endothelial protein C receptor in human neutrophils Blood 2003, 102:1499-1505. 10.1182/blood-2002-12-3880 12714492
37. Hill LL Chen DL Kozlowski J Schuster DP Neutrophils and neutrophil products do not mediate pulmonary hemodynamic effects of endotoxin on oleic acid-induced lung injury Anesth Analg 2004, 98:452-457. table 10.1213/01.ANE.0000097167.39112.A3 14742386
38. Hofman WF Ehrhart IC Permeability edema in dog lung depleted of blood components J Appl Physiol 1984, 57:147-153. 6206040
39. Wang L Zhu DM Su X Bai CX Ware LB Matthay MA Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs Exp Lung Res 2004, 30:31-42. 14967602
40. Furue S Kuwabara K Mikawa K Nishina K Shiga M Maekawa N Ueno M Chikazawa Y Ono T Hori Y Matsukawa A Yoshinaga M Obara H Crucial role of group IIA phospholipase A(2) in oleic acid-induced acute lung injury in rabbits Am J Respir Crit Care Med 1999, 160:1292-1302. 10508821
41. Goff CD Corbin RS Theiss SD Frierson HF Jr Cephas GA Tribble CG Kron IL Young JS Postinjury thromboxane receptor blockade ameliorates acute lung injury Ann Thorac Surg 1997, 64:826-829. 10.1016/S0003-4975(97)00490-6 9307481
42. Ishitsuka Y Moriuchi H Hatamoto K Yang C Takase J Golbidi S Irikura M Irie T Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs J Pharm Pharmacol 2004, 56:513-520. 10.1211/0022357023150 15099446
43. Rostagno C Gensini GF Boncinelli S Marsili M Castellani S Lorenzi P Merciai V Linden M Chelucci GL Cresci F The prominent role of thromboxane A2 formation on early pulmonary hypertension induced by oleic acid administration in sheep Thromb Res 1990, 58:35-45. 10.1016/ 0049-3848(90)90241-4 2343443
44. Thies SD Corbin RS Goff CD Binns OA Buchanan SA Shockey KS Frierson HF Jr Young JS Tribble CG Kron IL Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury Ann Thorac Surg 1996, 61:1453-1457. 10.1016/0003-4975(96)00077-X 8633958
45. Menschikowski M Hagelgans A Hempel U Lattke P Ismailov I Siegert G On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A(2) expression Thromb Res 2008, 122:69-76. 10.1016/j.thromres.2007.08.015 17936881
46. Brueckmann M Horn S Lang S Fukudome K Schulze NA Hoffmann U Kaden JJ Borggrefe M Haase KK Huhle G Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1 Thromb Haemost 2005, 93:743-750. 15841323
47. He X Han B Mura M Xia S Wang S Ma T Liu M Liu Z Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats Shock 2007, 28:106-111. 10.1097/SHK.0b013e3180310f3a 17510605
48. Vadasz I Morty RE Kohstall MG Olschewski A Grimminger F Seeger W Ghofrani HA Oleic acid inhibits alveolar fluid reabsorption: A role in acute respiratory distress syndrome? Am J Respir Crit Care Med 2005, 171:469-479. 10.1164/rccm.200407-954OC 15542790
49. Richardson MA Gupta A O'Brien LA Berg DT Gerlitz B Syed S Sharma GR Cramer MS Heuer JG Galbreath EJ Grinnell BW Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response J Pharmacol Exp Ther 2008, 325:17-26. 10.1124/jpet.107.130609 18182560